微泡
胶质母细胞瘤
转移
癌症研究
肿瘤进展
医学
小RNA
生物
癌症
内科学
基因
遗传学
作者
Seyedeh Nasibeh Mousavikia,Leili Darvish,Mohammad Taghi Bahreyni Toossi,Hosein Azimian
出处
期刊:Life Sciences
[Elsevier BV]
日期:2024-05-26
卷期号:350: 122743-122743
被引量:9
标识
DOI:10.1016/j.lfs.2024.122743
摘要
Exosomes are crucial for the growth and spread of glioblastomas, an aggressive form of brain cancer. These tiny vesicles play a crucial role in the activation of signaling pathways and intercellular communication. They can also transfer a variety of biomolecules such as proteins, lipids and nucleic acids from donor to recipient cells. Exosomes can influence the immune response by regulating the activity of immune cells, and they are crucial for the growth and metastasis of glioblastoma cells. In addition, exosomes contribute to drug resistance during treatment, which is a major obstacle in the treatment of glioblastoma. By studying them, the diagnosis and prognosis of glioblastoma can be improved. Due to their high biocompatibility and lack of toxicity, they have become an attractive option for drug delivery. The development of exosomes as carriers of specific therapeutic agents could overcome some of the obstacles to effective treatment of glioblastoma. In this review, we address the potential of exosomes for the treatment of glioblastoma and show how they can be modified for this purpose.
科研通智能强力驱动
Strongly Powered by AbleSci AI